Key Takeaways
- Steel Dynamics (STLD) reported robust Q3 2025 earnings, with revenue of $4.83 billion and EPS of $2.74, both surpassing Wall Street estimates, bolstered by a decrease in unfairly traded imports.
- Boeing (BA) and its striking union are set to resume mediated negotiations for a second day, aiming to resolve an 11-week labor dispute that has impacted defense production.
- Teva Pharmaceutical Industries Ltd. (TEVA) and Prestige Biopharma have inked a significant licensing deal for the commercialization of the biosimilar Tuznue® across 31 European markets.
- The United States and Australia formalized an $8.5 billion critical minerals agreement to counter China's dominance in rare earths, establishing a framework for securing vital supply chains.
- Dye & Durham Ltd. (DND) confirmed its intention to allocate $30 million from the sale of Credas Technologies for debt repayment, expecting to maintain financial compliance by March 31, 2026.
Steel Dynamics Exceeds Q3 Expectations Amid Favorable Trade Conditions
Steel Dynamics Inc. (STLD) announced strong third-quarter 2025 financial results, with revenue reaching $4.83 billion, slightly above analyst projections of $4.797 billion. The steel producer and metals recycler also reported a net income of $404 million, translating to earnings per share (EPS) of $2.74, which comfortably beat IBES estimates of $2.64 per share.
The company highlighted that a decrease in unfairly traded imports was a key positive factor contributing to its performance. Stronger demand across various sectors also played a role in the favorable results.
Boeing and Striking Union Continue Mediated Talks
Boeing (BA) and its striking union are engaged in a second day of mediated talks, seeking to resolve a protracted labor dispute. The ongoing 11-week strike by over 3,200 defense workers has significantly impacted the production of F-15EX fighter jets and munitions for the U.S. Air Force, causing concern among officials.
The International Association of Machinists and Aerospace Workers (IAM) District 837, representing the striking employees, confirmed the resumption of negotiations with the assistance of a federal mediator. The union has previously accused Boeing of not negotiating in good faith, while the company maintains its offer is fair.
Teva and Prestige Biopharma Partner for European Biosimilar Commercialization
Teva Pharmaceutical Industries Ltd. (TEVA) has entered into a licensing and supply agreement with Prestige Biopharma for the commercialization of Tuznue® (trastuzumab) in Europe. Tuznue® is a biosimilar to Roche's blockbuster oncology drug Herceptin®, approved for the treatment of breast and metastatic gastric cancers.
Under the terms of the deal, Teva will gain exclusive commercialization rights for Tuznue® across 31 European markets, leveraging its extensive commercial network. Prestige Biopharma had received European Commission (EC) marketing authorization for Tuznue® in September 2024.
US and Australia Forge $8.5 Billion Critical Minerals Pact
In a significant move to reshape global supply chains, President Donald Trump and Australian Prime Minister Anthony Albanese signed an $8.5 billion critical minerals deal at the White House. This historic accord aims to counter China's long-standing dominance in rare earth elements and other strategic materials.
The partnership establishes a framework for reducing Western dependence on Chinese-controlled resources and positions Australia as a cornerstone of an alternative supply network. The agreement encompasses a comprehensive investment pipeline valued at $8.5 billion for ready-to-implement mining projects, with the U.S. seeking ownership stakes in Australian mining operations to ensure long-term supply security.
Dye & Durham Outlines Debt Repayment Strategy
Dye & Durham Ltd. (DND) provided an update on its financial strategy, confirming that its financial advisor has engaged directly with Plantro to understand its proposal. The company plans to use $30 million from the recent sale of its Credas Technologies unit for debt repayment.
This move is expected to help the company remain in compliance with its financial covenants by March 31, 2026, through these proceeds and normal operating cash management.
Broader Economic Landscape
In other news, the ongoing government shutdown continues to have felt consequences across various sectors. Meanwhile, the Bank of Canada noted that firms' outlooks remain subdued, a sentiment attributed to persistent trade tensions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.